Lonza | LONN - Ebitda

Stock Price
527.40
Daily Change
3.60 0.69%
Monthly
-4.46%
Yearly
-8.53%
Q1 Forecast
523.37

Lonza reported CHF1.01B in EBITDA for its fiscal semester ending in December of 2025.





Ebitda Change Date
Akzo Nobel EUR 385M 8M Sep/2025
Alcon AG USD 654M 404M Sep/2025
AstraZeneca USD 5.23B 272M Sep/2025
BASF EUR 1.54B 228M Sep/2025
Bayer EUR 1.51B 1.28B Sep/2025
Beiersdorf EUR 984M 147M Jun/2025
Covestro EUR 242M 24M Sep/2025
Demant DKK 2.76B 165M Dec/2025
Fresenius EUR 850M 22M Sep/2025
Fresenius Medical Care EUR 1.07B 142.74M Dec/2025
Geberit CHF 236M 1.1M Sep/2025
Genmab DKK 477M 101M Sep/2025
Givaudan CHF 778M 195M Dec/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
GN Store Nord DKK 627M 106M Dec/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Johnson Matthey GBP 325M 52M Jun/2024
Merck EUR 1.46B 45M Jun/2025
Novartis USD 5.88B 290M Sep/2025
Philips EUR 738M 9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 4.84B 2.95B Sep/2025
Sika AG CHF 1.07B 106.25M Jun/2025
Smith & Nephew USD 796M 139M Dec/2025
Solvay EUR 169M 63M Dec/2025
UCB EUR 1.03B 334M Jun/2025